Market Research Logo

Cepheid (CPHD) - Financial and Strategic SWOT Analysis Review

Cepheid (CPHD) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Cepheid is a molecular diagnostic company which develops, manufactures, and markets accurate and easy-to-use molecular systems and tests for clinical and non-clinical markets. The company offers invitro diagnostic tests for health care associated infections, critical infectious diseases, sexual health, and oncology and genetics; systems that integrate sample preparation, DNA amplification and detection and analyze complex biological samples in our proprietary test cartridges; industrial reagents and parts and accessories for its systems. The company operates through its subsidiaries in France, Sweden, the US, Japan, Germany, South Africa, the UK, Belgium, Australia, the UAE, China, Italy, Singapore, Brazil, India, and Hong Kong. Cepheid is headquartered in Sunnyvale, California, the US.

Cepheid Key Recent Developments

Apr 28, 2016: Cepheid Reports First Quarter 2016 Results
Apr 21, 2016: Cepheid Announces Partner Distribution Agreement With Medline
Feb 10, 2016: Cepheid Announces Appointment of President and Chief Operating Officer and Welcomes Executive Vice President of Engineering and Operations
Feb 02, 2016: Cepheid Reports Fourth Quarter And Full Year 2015 Results
Jan 11, 2016: Cepheid Schedules 2015 Fourth Quarter And Full Year Results Announcement And Webcast

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Cepheid - Key Facts
Cepheid - Key Employees
Cepheid - Key Employee Biographies
Cepheid - Major Products and Services
Cepheid - History
Cepheid - Company Statement
Cepheid - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Cepheid - Business Description
Cepheid - Corporate Strategy
Cepheid - SWOT Analysis
SWOT Analysis - Overview
Cepheid - Strengths
Strength - Research and Development
Strength - The GeneXpert System
Strength - Improved Liquidity
Strength - Improved Performance of Clinical Reagents Market
Cepheid - Weaknesses
Weakness - Operating Loss Carryforward
Weakness - Contract Termination Dispute
Cepheid - Opportunities
Opportunity - Strategic Initiatives
Opportunity - Growing Market for IVD Tests
Opportunity - Focus on Ebola Virus Disease
Cepheid - Threats
Threat - Competitive Life Sciences Market
Threat - Limited Supplier Base
Threat - Variable Operating Results
Cepheid - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Cepheid, Medical Equipment, Deals By Year, 2010 to YTD 2016
Cepheid, Medical Equipment, Deals By Type, 2010 to YTD 2016
Cepheid, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 28, 2016: Cepheid Reports First Quarter 2016 Results
Apr 27, 2016: Quidel Reports First Quarter 2016 Financial Results
Apr 21, 2016: Cepheid Announces Partner Distribution Agreement With Medline
Mar 09, 2016: Cepheid Announces First FDA-Cleared Test for Detection of Carbapenem Resistance Genes in Isolates of Multidrug Resistant 'Superbugs'
Mar 03, 2016: Nanosphere’s Verigene BC-GP Decreases Patient Length of Stay
Feb 24, 2016: Nanosphere Announces Fourth Quarter and Full Year 2015 Results, 2016 Guidance and Next Generation Verigene Progress
Feb 17, 2016: Quidel Reports Fourth Quarter and Full Year 2015 Financial Results
Feb 10, 2016: Cepheid Announces Appointment of President and Chief Operating Officer and Welcomes Executive Vice President of Engineering and Operations
Feb 02, 2016: Cepheid Reports Fourth Quarter And Full Year 2015 Results
Jan 25, 2016: Quidel Receives CE Mark for Its New Sofia Fluorescent Immunoassay for Diagnosis of Pneumococcal Pneumonia and Pneumococcal Meningitis
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Cepheid, Key Facts
Cepheid, Key Employees
Cepheid, Key Employee Biographies
Cepheid, Major Products and Services
Cepheid, History
Cepheid, Subsidiaries
Cepheid, Key Competitors
Cepheid, Ratios based on current share price
Cepheid, Annual Ratios
Cepheid, Interim Ratios
Cepheid, Medical Equipment, Deals By Year, 2010 to YTD 2016
Cepheid, Medical Equipment, Deals By Type, 2010 to YTD 2016
Cepheid, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Cepheid, Performance Chart (2011 - 2015)
Cepheid, Ratio Charts
Cepheid, Medical Equipment, Deals By Year, 2010 to YTD 2016
Cepheid, Medical Equipment, Deals by Type, 2010 to YTD 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report